Log In
Print
BCIQ
Print
Print this Print this
 

Epogen, Espo

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionRecombinant human erythropoietin (EPO)
Molecular Target Erythropoietin (EPO) receptor
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat renal anemia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today